Table 1. Patient characteristics Patient... | American Society of Hematology

Table 1.

Patient characteristics

Patient #	Sex	First symptoms after vaccination (d)	Thrombosis	Platelet count	D-Dimer	PF4–heparin–EIA (OD)	Platelet activation with PF4 (modified HIPA)
1	M	16	SVT/DVT/PE	60	12	3.4	+
2	M	8	SVT	22	n.a	3.1	+
3	F	6	SVT	40	n.a	2.2	+
4	F	9	SVT	27	54	3.2	+
5	F	7	SVT	53	35	3.1	+
6	F	5	SVT	56	9	2.1	+
7	M	9	DVT/PE	8	>35	3.2	+
8	M	12	DVT/PE	60	n.a.	3.0	+

Patient #	Sex	First symptoms after vaccination (d)	Thrombosis	Platelet count	D-Dimer	PF4–heparin–EIA (OD)	Platelet activation with PF4 (modified HIPA)
1	M	16	SVT/DVT/PE	60	12	3.4	+
2	M	8	SVT	22	n.a	3.1	+
3	F	6	SVT	40	n.a	2.2	+
4	F	9	SVT	27	54	3.2	+
5	F	7	SVT	53	35	3.1	+
6	F	5	SVT	56	9	2.1	+
7	M	9	DVT/PE	8	>35	3.2	+
8	M	12	DVT/PE	60	n.a.	3.0	+

F, female; M, male; OD, optical density.